CareDx, Inc (CDNA)
NASDAQ: CDNA · Real-Time Price · USD
17.81
-0.09 (-0.50%)
At close: Nov 26, 2025, 4:00 PM EST
17.40
-0.41 (-2.30%)
After-hours: Nov 26, 2025, 6:24 PM EST
CareDx Employees
As of December 31, 2024, CareDx had 650 total employees, including 644 full-time and 6 part-time employees. The number of employees increased by 7 or 1.09% compared to the previous year.
Employees
650
Change (1Y)
7
Growth (1Y)
1.09%
Revenue / Employee
$550,766
Profits / Employee
$108,386
Market Cap
916.02M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 650 | 7 | 1.09% |
| Dec 31, 2023 | 643 | -95 | -12.87% |
| Dec 31, 2022 | 738 | 93 | 14.42% |
| Dec 31, 2021 | 645 | 170 | 35.79% |
| Dec 31, 2020 | 475 | 89 | 23.06% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CDNA News
- 2 days ago - SHORE Study Demonstrates HeartCare's Prognostic Value for Heart Transplant Recipients, Published in Journal of Heart and Lung Transplantation - Business Wire
- 16 days ago - CareDx to Participate in Upcoming Investor Conferences - Business Wire
- 19 days ago - CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 20 days ago - CareDx Announces New Precision Kidney Transplant Data and Product Innovations at ASN Kidney Week 2025 - Business Wire
- 22 days ago - CareDx, Inc (CDNA) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 22 days ago - CareDx Announces Third Quarter 2025 Financial Results - Business Wire
- 4 weeks ago - CareDx Announces Appointment of Jeffrey John Teuteberg, MD as Chief Medical Officer - Business Wire
- 4 weeks ago - CareDx Announces Largest Landmark Study of Its Kind on Antibody Mediated Rejection in Heart Transplantation Published in Journal of the American College of Cardiology: Heart Failure - Business Wire